TriSalus Life Sciences (NASDAQ:TLSIW) Share Price Breaks Above 50-Day Moving Average – Here’s Why

TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $0.87 and traded as high as $0.9357. TriSalus Life Sciences shares last traded at $0.9290, with a volume of 1,826 shares.

TriSalus Life Sciences Trading Up 14.7%

The firm has a 50-day simple moving average of $0.87 and a two-hundred day simple moving average of $0.96.

Institutional Trading of TriSalus Life Sciences

An institutional investor recently bought a new stake in TriSalus Life Sciences stock. State Street Corp bought a new stake in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 610,963 shares of the company’s stock, valued at approximately $2,780,000.

TriSalus Life Sciences Company Profile

(Get Free Report)

TriSalus Life Sciences is a medical technology and therapeutics company focused on improving treatment delivery for patients with solid tumors, particularly tumors in the liver and pancreas. Its approach combines proprietary drug-delivery technology with the development of immunotherapies. The company’s TriNav® infusion system is designed to deliver therapies into tumors using its Pressure-Enabled Drug Delivery (PEDD) approach. TriSalus is also developing investigational therapies intended to work alongside its delivery platform; these therapies are not established treatments.

Recommended Stories

Receive News & Ratings for TriSalus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriSalus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.